Testing a new pain drug called Radiocaine
This study tests whether a new numbing medicine, called Radiocaine, is safe and works well for pain. You will have imaging scans and blood tests to see how the drug acts in your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must not weigh more than 300 pounds and your BMI must be under 32.
- You must be willing to have blood tests, heart monitoring, and imaging scans.
- You must be free of conditions like severe depression, anxiety, or a history of seizures.
- You must not have had major surgery or taken certain heart or seizure medicines recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a procedure called radiofrequency denervation to reduce long-lasting, mostly “pain-from-joints/structures” low back pain, and it uses brain imaging to understand what changes during treatment. It may help people who already showed they respond well to a similar diagnostic nerve block.
This study tests whether an ultrasound-guided numbing injection in the belly wall can reduce pain during heart procedures like angioplasty or stent placement. It is for people having planned (non-emergency) heart catheterization.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This Phase 1/2 study tests hydroxynorketamine (a related ketamine-type medicine) to see if it can reduce chronic nerve pain in the arms or legs. You may be able to join if you have nerve pain for more than 3 months and meet safety and health check requirements.
This trial tests an investigational drug called VER-01 for people with long-term pain from a pinched nerve in the lower back. It aims to see if the drug safely reduces pain and improves daily life.
This Phase 1 study tests whether a combination of pain medicines (bupivacaine plus ketorolac and ketamine) works better than bupivacaine alone to reduce pain after placing a new heart device. If you get a new pacemaker/ICD/CRT device and meet other safety rules, you may be asked to join.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.